Category Archives: Pharmaceuticals & Biotech
NeurAxis Inc. (NYSE-Amer: NRXS) proves that a smallcap biotech can deliver best-in-market care. That’s more than great news for NRXS from a revenue perspective and for its patients from a treatment point of view. It can also be excellent news for … Continue reading
Laboratory Freezers Market Projected to Reach $5.7 Billion by 2026 | MarketsandMarkets™ Study
Browse 274 market data Tables and 52 Figures spread through 291 Pages and in-depth TOC on “Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) – Global … Continue reading
Browse 200 market data Tables and 45 Figures spread through 230 Pages and in-depth TOC on “Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary … Continue reading
$4.9 Billion Forecasted for the Empty Capsules Market by 2028
Browse 247 market data Tables and 38 Figures spread through 248 Pages and in-depth TOC on “Empty Capsules Market by Type (Gelatin, Non-gelatin), Functionality (Immediate-release, Sustained-release, Delayed Release), Therapeutic Application, End User (Pharmaceutical, Nutraceutical, Cosmetic, Reference Laboratories) – Global Forecast … Continue reading
“The Breast Cancer Biomarker Market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Breast Cancer Biomarker pipeline products will significantly revolutionize the Breast Cancer Biomarker market dynamics” … Continue reading
“The Metastatic Prostate Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Metastatic Prostate Cancer pipeline products will significantly revolutionize the Metastatic Prostate Cancer market dynamics” … Continue reading
“The HER2-Positive Breast Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- HER2-Positive Breast Cancer pipeline products will significantly revolutionize the HER2-Positive Breast Cancer market dynamics” … Continue reading
“The Non-Small Cell Lung Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Non-Small Cell Lung Cancer pipeline products will significantly revolutionize the Non-Small Cell Lung … Continue reading
“The Multiple Myeloma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Multiple Myeloma pipeline products will significantly revolutionize the Multiple Myeloma market dynamics” The Multiple … Continue reading
“The Acute Myeloid Leukemia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Acute Myeloid Leukemia pipeline products will significantly revolutionize the Acute Myeloid Leukemia market dynamics” … Continue reading